Smith & Nephew (SNN) Shares Outstanding (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Shares Outstanding (Entity) of $867.0 million for Q4 2025, down 0.69% year-on-year from $873.0 million in Q4 2024, and down 0.69% on a QoQ basis from $873.0 million in Q4 2024.
Smith & Nephew (SNN) Shares Outstanding (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Shares Outstanding (Entity) for 17 consecutive years, with $867.0 million the latest figure, recorded in Q4 2025.
- Quarterly Shares Outstanding (Entity) fell 0.69% year-over-year to $867.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $867.0 million (down 0.69% YoY) and the FY2025 annual result came in at $867.0 million, down 0.69% from the prior year.
- Shares Outstanding (Entity) declined to $867.0 million in Q4 2025 per SNN's latest filing, from $873.0 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for SNN reached as high as $877.0 million in Q4 2021 and fell as low as $867.0 million in Q4 2025.
- A 5-year average of $872.0 million and a median of $872.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) increased 0.23% — and 2025, when it retreated 0.69%.
- Year by year, Shares Outstanding (Entity) stood at $877.0 million in 2021, then slipped by 0.57% to $872.0 million in 2022, then declined by 0.11% to $871.0 million in 2023, then rose by 0.23% to $873.0 million in 2024, then retreated by 0.69% to $867.0 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $867.0 million, $873.0 million, and $871.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 98.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 867.00 Mn |
| Jun 28, 2025 | 873.00 Mn |
| Dec 31, 2024 | 873.00 Mn |
| Jun 29, 2024 | 871.00 Mn |
| Dec 31, 2023 | 871.00 Mn |
| Dec 31, 2022 | 872.00 Mn |
| Dec 31, 2021 | 877.00 Mn |
| Dec 31, 2020 | 875.00 Mn |
| Jun 30, 2020 | 874.00 Mn |
| Dec 31, 2019 | 874.00 Mn |
| Jun 29, 2019 | 873.00 Mn |
| Dec 31, 2018 | 873.00 Mn |
| Jun 30, 2018 | 874.00 Mn |
| Dec 31, 2017 | 874.00 Mn |
| Dec 31, 2016 | 890.00 Mn |
| Dec 31, 2015 | 894.00 Mn |
| Jun 30, 2015 | 894.00 Mn |
| Dec 31, 2014 | 901.00 Mn |
| Sep 30, 2014 | 2.26 Bn |
| Jun 28, 2014 | 2.23 Bn |